Boston, MA, United States of America

Pat Horn

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Pat Horn

Introduction

Pat Horn is a distinguished inventor based in Boston, MA, with a significant contribution to the field of medical treatments. He has made strides in addressing progressive familial intrahepatic cholestasis (PFIC), a rare liver disease that affects children. His innovative approach through the use of IBAT inhibitors showcases his commitment to improving patient outcomes.

Latest Patents

Pat Horn holds a patent related to treating progressive familial intrahepatic cholestasis (PFIC) with IBAT inhibitors. This patent encompasses methods for treating PFIC using an ileal bile acid transport (IBAT) inhibitor, such as odevixibat or a pharmaceutically acceptable salt thereof. The methods outlined in the patent focus on several positive outcomes, including reducing mean pruritus score, decreasing mean serum bile acid concentration, increasing height, normalizing weight, improving sleep, and enhancing liver parameters.

Career Highlights

Currently, Pat Horn is employed at Albireo AB, a company focused on developing innovative therapeutics for liver diseases. His work is characterized by a blend of research and practical application, demonstrating his dedication to advancing medical science and patient care. With one patent to his name, Horn exemplifies the intersection of innovation and clinical necessity.

Collaborations

Throughout his career, Pat has collaborated with notable colleagues in the field, including Per-Göran Gillberg and Jan Mattsson. These collaborations reflect a shared commitment to research and development that aims to transform medical treatment and improve quality of life for patients suffering from debilitating conditions.

Conclusion

Pat Horn represents a significant figure in the world of medical innovation, particularly in the treatment of rare liver diseases. His patent exemplifies the potential for scientific advancements to lead to improved therapeutic outcomes. As a dedicated member of Albireo AB, he continues to push the boundaries of research and application, aiming to bring meaningful change to the lives of those affected by PFIC.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…